However, its prevalence in T-ALL and its clear role in oncogenic signaling, led the authors to describe ribosomes containing this mutated form of uL16 as ‘onco-ribosomes’ (45), although it is likely just one example of specialized ribosomes supporting oncogenic phenotypes (46). Here, RPL10 is linked to acute lymphoblastic leukemia.